#IIoT_World™ is the first Global #DigitalPublication focused 100% on Industrial AI, #IIoT, #ICS #security. #1 Industrial IoT #Influencer.
United States
Joined January 2017
- Tweets38.3K
- Following30.1K
- Followers53.3K
- Likes45K
When an AI agent recommends a process change on a pharma production line, the recommendation itself is secondary. The defensible record of how the agent reached that recommendation is what regulators actually audit. Merck's team treats AI output as evidence. Partner content with Adlib.
ALCOA requires every pharma record to be Attributable, Legible, Contemporaneous, Original, and Accurate. At Merck, that standard applies to AI-generated decisions with the same force it applies to human ones, which changes how agents must be architected from the start.
Thorlux discovered something shocking during migration: one ingestion routine was executing 8,000 separate database queries to insert a single report. Took minutes. Rewrote it as one batched query. Same operation: now takes seconds.
The database migration revealed the real problem was in the application layer. Read the full case study in the first reply. Partner content with @TigerDatabase. #tigerdata_ai
AI agents carry no sense of reputation, career, or penalty for rationalized misbehavior. Gary Tillery of Skkynet says the gap is closed by making the agent a platform object whose identity outlives any model, with authority re-issued only against the current stack. Partner content with @skkynetinc. #skkynet_ai
Tillery describes a clear operating split. Domain teams, the humans, own the job, meaning the prompt, the tool allowlist, and the evaluation suite that defines whether the agent is still doing its job.
Factories carry 30% to 40% additional cost in spare lines, backup equipment stored for 12 to 18 months without use, and thousands of engineers on call, all because no system could reliably predict when a specific component would fail. The only defense was duplication. Partner content with @AI4ProdOutcomes. #infinite_ai
Prescriptive AI that identifies machine state precisely enough to predict remaining useful life can begin engineering plant redundancy out of plant design itself, reducing spare lines, reallocating on-call engineers, and reconsidering how much backup capacity a production line truly needs.
25.7% of CPG manufacturers cite workforce resistance as a barrier to AI scaling. Schneider Electric recommends engaging operations and maintenance teams early when identifying AI use cases and keeping them involved through deployment.
Organizations seeing the best AI ROI are often the same ones seeing improvements in workforce engagement, retention, and capability, according to Schneider Electric's research. A people-centric approach and financial returns reinforce each other.
Decision lineage is a gap pharma AI teams have not closed. Knowing which document informed an AI answer is progress, but Merck's Procopio says you need to know which downstream analyses, submissions, and decisions were influenced by that document, especially when source information changes. Partner content with Adlib. #adlib_iiot
Automated reassessment when source information changes remains an active area of development, per Procopio. Pharma organizations using AI for regulatory submissions cannot yet rely on systems to flag cascading impact automatically.